CELL THERAPEUTICS IN DEAL WITH NOVARTIS

Cell Therapeutics Inc., a maker of treatments for cancer, said Monday it entered into a licensing agreement worth up to $285 million with drug maker Novartis AG for a cancer drug in clinical trials. MSN Money (http://news.moneycentral.msn.com/provider/providerarticle.asp?feed=AP&Date=20060918&ID=6028795)